Corcept Therapeutics Inc Insider Selling: Roberto Wandenkolk Vieira Trims Stake

A Form 4 filed with the SEC shows Roberto Wandenkolk Vieira, Pres, Oncology at Corcept Therapeutics Inc (CORT), sold 296 shares of company stock on 2026-09-16.

The transaction was executed at a price of $100.82 per share, for a total value of approximately $29,843.

Under SEC rules, corporate insiders — officers, directors, and holders of more than 10% of a company's shares — are required to report changes in their ownership within two business days of the transaction via Form 4.

Insider sales are common and can occur for reasons unrelated to a company's outlook, including scheduled trading plans, diversification, or personal financial planning.